- We will send in 10–14 business days.
/images/books/12405646/9781849738828.jpg)
- Publisher: Royal Society of Chemistry
- Year: 2015
- Pages: 336
- ISBN-10: 1849738823
- ISBN-13: 9781849738828
- Format: 16.3 x 23.6 x 2.3 cm, kieti viršeliai
- Language: English
- SAVE -10% with code: EXTRA
Epigenetics for Drug Discovery (e-book) (used book) | bookbook.eu
Reviews
Description
Epigenetics is one of the fastest moving fields in drug discovery, with almost every large pharmaceutical company and a substantial number of biotechnology companies targeting epigenetic processes to treat diseases ranging from cancer to Huntington's disease and from inflammation to sickle cell anaemia.
The book is structured in three main sections. The first section introduces epigenetics and explain its importance at both a phenomenological and molecular level. The second section goes on to review how each of the big breakthroughs in drug discovery in this field have developed, with a strong emphasis on case histories. The final section highlights the ongoing challenges in creating safe and efficacious epigenetic drugs.
Written and edited by experts within the field from both industry and academia, this book provides an invaluable guide to this developing field for medicinal chemists working in academia and in the pharmaceutical industry.
EXTRA 10 % discount with code: EXTRA
The promotion ends in 21d.14:15:57
The discount code is valid when purchasing from 10 €. Discounts do not stack.
- Publisher: Royal Society of Chemistry
- Year: 2015
- Pages: 336
- ISBN-10: 1849738823
- ISBN-13: 9781849738828
- Format: 16.3 x 23.6 x 2.3 cm, kieti viršeliai
- Language: English English
Epigenetics is one of the fastest moving fields in drug discovery, with almost every large pharmaceutical company and a substantial number of biotechnology companies targeting epigenetic processes to treat diseases ranging from cancer to Huntington's disease and from inflammation to sickle cell anaemia.
The book is structured in three main sections. The first section introduces epigenetics and explain its importance at both a phenomenological and molecular level. The second section goes on to review how each of the big breakthroughs in drug discovery in this field have developed, with a strong emphasis on case histories. The final section highlights the ongoing challenges in creating safe and efficacious epigenetic drugs.
Written and edited by experts within the field from both industry and academia, this book provides an invaluable guide to this developing field for medicinal chemists working in academia and in the pharmaceutical industry.
Reviews